Fox Run Management, L.L.C. Beam Therapeutics Inc. Transaction History
Fox Run Management, L.L.C.
- $553 Million
- Q2 2025
A detailed history of Fox Run Management, L.L.C. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 15,775 shares of BEAM stock, worth $421,665. This represents 0.05% of its overall portfolio holdings.
Number of Shares
15,775Holding current value
$421,665% of portfolio
0.05%Shares
2 transactions
Others Institutions Holding BEAM
# of Institutions
247Shares Held
95.6MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$268 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$259 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$237 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$204 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.83MShares$129 Million0.07% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.88B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...